141 related articles for article (PubMed ID: 20816914)
21. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
22. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
[TBL] [Abstract][Full Text] [Related]
23. Activation of CCL20 and its receptor CCR6 promotes endometrium preparation for implantation and placenta development during the early pregnancy period in pigs.
Park C; Bae H; Bazer FW; Song G; Lim W
Dev Comp Immunol; 2019 Mar; 92():35-42. PubMed ID: 30414404
[TBL] [Abstract][Full Text] [Related]
24. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
[TBL] [Abstract][Full Text] [Related]
25. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
26. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
27. CCL20/CCR6 expression profile in pancreatic cancer.
Rubie C; Frick VO; Ghadjar P; Wagner M; Grimm H; Vicinus B; Justinger C; Graeber S; Schilling MK
J Transl Med; 2010 May; 8():45. PubMed ID: 20459729
[TBL] [Abstract][Full Text] [Related]
28. Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy.
Chen XB; Regan JW
Cell Mol Life Sci; 2006 Jan; 63(1):112-21. PubMed ID: 16378246
[TBL] [Abstract][Full Text] [Related]
29. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of Ca(2+)-dependent Cl- currents by FP prostanoid receptor isoforms in Xenopus oocytes.
Anthony TL; Fujino H; Pierce KL; Yool AJ; Regan JW
Biochem Pharmacol; 2002 May; 63(10):1797-806. PubMed ID: 12034364
[TBL] [Abstract][Full Text] [Related]
31. Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton.
Pierce KL; Fujino H; Srinivasan D; Regan JW
J Biol Chem; 1999 Dec; 274(50):35944-9. PubMed ID: 10585482
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C.
Fujino H; Srinivasan D; Pierce KL; Regan JW
Mol Pharmacol; 2000 Feb; 57(2):353-8. PubMed ID: 10648645
[TBL] [Abstract][Full Text] [Related]
33. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
34. The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.
Zhang J; Zhu D; Lv Q; Yi Y; Li F; Zhang W
Tumour Biol; 2015 Dec; 36(12):9763-7. PubMed ID: 26156805
[TBL] [Abstract][Full Text] [Related]
35. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
[TBL] [Abstract][Full Text] [Related]
36. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
37. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
[TBL] [Abstract][Full Text] [Related]
38. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.
Lisignoli G; Manferdini C; Codeluppi K; Piacentini A; Grassi F; Cattini L; Filardo G; Facchini A
J Cell Physiol; 2009 Oct; 221(1):154-60. PubMed ID: 19492413
[TBL] [Abstract][Full Text] [Related]
39. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
40. Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer.
Baran K; Kordiak J; Jabłoński S; Brzeziańska-Lasota E
Sci Rep; 2023 Jun; 13(1):9642. PubMed ID: 37316552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
